| Detected | Trial | Change |
|---|---|---|
| 2026-07-22 | NCT05693142 AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy… |
overall status: Recruiting → Active, Not Recruiting |
| 2026-07-22 | NCT05693142 AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy… |
Trial sites expanded: 17 -> 23 locations |
| 2026-07-22 | NCT05693142 AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy… |
date change Primary completion pushed: 2026-08 -> 2026-09 |
| 2026-07-22 | NCT05693142 AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy… |
date change Completion moved earlier: 2028-08 -> 2028-06 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07236606 | RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome) | MPS II | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT03566043 | CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome) | Mucopolysaccharidosis Type II (MPS II) | Active, Not Recruiting |
| NCT05693142 | AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy… | Duchenne Muscular Dystrophy | Active, Not Recruiting |
| Not specified | |||
| NCT06491927 | Long Term Follow-up for RGX-202 | Duchenne Muscular Dystrophy | Enrolling by Invitation |
| NCT06103487 | Long Term Follow-Up for RGX-111 | Mucopolysaccharidosis I | Enrolling by Invitation |
| NCT05683379 | AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD | Duchenne Muscular Dystrophy | Active, Not Recruiting |